Fibrocor and Galapagos sign expanded collaboration in fibrosis
(WorldNews Belgium)

Fibrocor and Galapagos sign expanded collaboration in fibrosis 15 Jan 2020 07:30 CET Company Name GALAPAGOS ISN BE0003818359 Market Euronext Symbol GLPG Fibrocor and Galapagos sign expanded collaboration in fibrosis Mechelen, Belgium and Toronto, Canada; 15 January 2020, 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) and Fibrocor Therapeutics Inc. (Fibrocor) today announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos taking an equity stake in Fibrocor. Fibrocor is a privately held Canadian company specializing in the development of tissue-specific therapeutics to treat fibrotic diseases of the kidney, liver, lung and other organs. To date, the company...